Kristen Keon Ciombor MD

Gastrointestinal Cancer, Hematologic Oncology

Assistant Professor of Medical Oncology

3601 21st Ave SNashville, TN 37232
Phone+1 615-936-2000
Fax+1 615-936-0605

Dr. Ciombor is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ciombor's full profile Already have an account?

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2005 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2005

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TN State Medical License 2017 - 2026
AL State Medical License 2020 - 2020
OH State Medical License 2013 - 2019
FL State Medical License 2008 - 2010
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017

Clinical Trials

Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations Start of enrollment: 2020 Aug 31
UNKNOWN
PHASE2

Publications & Presentations

PubMed

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.
Chan Shen, Madison Conces, Kristen Ciombor, Jennifer Dorth, Joshua E Meyer
The Oncologist. 2026-05-08
Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315).
Adel Mandl, Ruizhe Chen, Satya Das, Jonathan R Strosberg, Anup Kasi
The Oncologist. 2026-05-08
2 citations
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
Van K Morris, Kristen K Ciombor, Lianchun Xiao, Joshua K Ochieng, Enrica Marmonti
Journal of Clinical Oncology. 2026-02-20

Lectures

NuTide: 302—A phase Ib study of the ProTide NUC-3373 in combination with standard therapies in advanced colorectal cancer.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

GI Cancer Research at ASCO25: Plenary Highlights and MoreJune 24th, 2025
Only Half of Young Cancer Patients Report a Discussion on Fertility PreservationNovember 12th, 2024
Underpinning the Advances, Challenges to Democratizing Precision OncologyDecember 3rd, 2022